Lund
Sweden
8
2019-02-21
5
2019-07-23
These are the the leading inventors for applications assigned to A1M Pharma AB:
A1M Pharma AB based in Lund, SE has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN CONNECTION WITH USE OF CONTRAST MEDIA
#2 | 2018-10-04 ✅ Patent 10,359,406 granted on 2019-07-23Diagnosis and treatment of preeclampsia
#3 | 2018-08-30 ✅ Patent 10,960,048 granted on 2021-03-30Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy
#4 | 2018-03-15BIOMARKERS FOR PREECLAMPSIA
#5 | 2015-09-17 ✅ Patent 10,226,507 granted on 2019-03-12Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
#6 | 2014-03-06DIAGNOSIS AND TREATMENT OF PREECLAMPSIA
#7 | 2011-08-04 ✅ Patent 10,350,268 granted on 2019-07-16Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
#8 | 2010-04-29 ✅ Patent 8,568,999 granted on 2013-10-29Diagnosis and treatment of preeclampsia
Also check out A1M Pharma AB's (Lund, Sweden) applicant profile with 2 patent applications submitted.
57289 ⎘